Methylenetetrahydrofolate reductase C677T genotype and PD

被引:44
作者
de Lau, LML
Koudstaal, PJ
van Meurs, JBJ
Uitterlinden, AG
Hofman, A
Breteler, MMB
机构
[1] Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus MC, Dept Neurol, NL-3000 DR Rotterdam, Netherlands
[3] Erasmus MC, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands
关键词
D O I
10.1002/ana.20509
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In a prospective, population-based cohort study among 5,920 participants aged 55 years or older, we observed that the TT variant of the methylenetetrahydrofolate reductase C677T polymorphism is associated with an increased risk for Parkinson's disease in smokers. Both smoking and the TT genotype are known to induce hyperhomocystinemia, and synergistic effects on homocysteine levels have been reported. Increased plasma levels of homocysteine through direct neurotoxic effects might accelerate the selective dopaminergic cell death underlying Parkinson's disease. Our findings support the hypothesis that homocysteine plays a role in the pathogenesis of Parkinson's disease.
引用
收藏
页码:927 / 930
页数:4
相关论文
共 16 条
[1]   Common carotid intima-media thickness and risk of stroke and myocardial infarction - The Rotterdam Study [J].
Bots, ML ;
Hoes, AW ;
Koudstaal, PJ ;
Hofman, A ;
Grobbee, DE .
CIRCULATION, 1997, 96 (05) :1432-1437
[2]   The 5,10-methylenetetrahydrofolate reductase C677T polymorphism interacts with smoking to increase homocysteine [J].
Brown, KS ;
Kluijtmans, LAJ ;
Young, IS ;
Murray, L ;
McMaster, D ;
Woodside, JV ;
Yarnell, JWG ;
Boreham, CA ;
McNulty, H ;
Strain, JJ ;
McPartlin, J ;
Scott, JM ;
Mitchell, LE ;
Whitehead, AS .
ATHEROSCLEROSIS, 2004, 174 (02) :315-322
[3]   Incidence of parkinsonism and Parkinson disease in a general population - The Rotterdam Study [J].
de Lau, LML ;
Giesbergen, PCLM ;
de Rijk, MC ;
Hofman, A ;
Koudstaal, PJ ;
Breteler, MMB .
NEUROLOGY, 2004, 63 (07) :1240-1244
[4]   Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic, neurons in models of Parkinson's disease [J].
Duan, W ;
Ladenheim, B ;
Cutler, RG ;
Kruman, II ;
Cadet, JL ;
Mattson, MP .
JOURNAL OF NEUROCHEMISTRY, 2002, 80 (01) :101-110
[5]  
Fahn S., RECENT DEV PARKINSON, V2, P153, DOI DOI 10.1002/ANA.410220556
[6]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[7]   Parkinson's - Divergent causes, convergent mechanisms [J].
Greenamyre, JT ;
Hastings, TG .
SCIENCE, 2004, 304 (5674) :1120-1122
[8]   Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damage [J].
Ho, PI ;
Ortiz, D ;
Rogers, E ;
Shea, TB .
JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (05) :694-702
[9]   DETERMINANTS OF DISEASE AND DISABILITY IN THE ELDERLY - THE ROTTERDAM ELDERLY STUDY [J].
HOFMAN, A ;
GROBBEE, DE ;
DEJONG, PTVM ;
VANDENOUWELAND, FA .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1991, 7 (04) :403-422
[10]   Effect of lifestyle factors on plasma total homocysteine concentrations in relation to MTHFR(C677T) genotype. Inter99 (7) [J].
Husemoen, LLN ;
Thomsen, TF ;
Fenger, M ;
Jorgensen, T .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2004, 58 (08) :1142-1150